ERBB2 and breast carcinoma: Our results show that metabolic genes in HER2-positive breast cancer were significantly enriched in purine metabolism, metabolism of xenobiotics by cytochrome pathway, tyrosine metabolism and drug metabolism, indicating that HER2-positive breast cancer is significantly related to amino acid metabolic pathways and drug metabolism.